MyFinsight
Home
Blog
About
Proceeds from
convertible senior notes,...
$335,513K
Proceeds from exercise of
stock options
$5,382K
(-23.78%↓ Y/Y)
Net cash provided by
financing activities
$142,188K
(1913.71%↑ Y/Y)
Canceled cashflow
$198,707K
Net increase
(decrease) in cash, cash...
$92,311K
(1970.92%↑ Y/Y)
Canceled cashflow
$49,877K
Revenue interest
liability extinguishment
$148,108K
Purchase of capped calls
$25,599K
Repurchase of common stock
$25,000K
Proceeds from maturities
of marketable...
$40,432K
(-69.51%↓ Y/Y)
Loss on revenue
interest liability...
$23,733K
Share-based compensation
expense
$11,119K
(-56.41%↓ Y/Y)
Deferred revenue
$3,659K
(148.07%↑ Y/Y)
Depreciation expense
$3,272K
(-61.01%↓ Y/Y)
Noncash lease expense
$1,126K
(-57.38%↓ Y/Y)
Accounts payable and
accrued liabilities
$1,010K
(115.79%↑ Y/Y)
something is missing
$655K
Inventory
-$561K
(-56.27%↓ Y/Y)
Intangible assets
amortization
$423K
(-49.76%↓ Y/Y)
Write-off of inventory
$12K
Net cash (used in)
provided by investing...
-$43,477K
(-250.34%↓ Y/Y)
Net cash used in
operating activities
-$6,400K
(84.36%↑ Y/Y)
Canceled cashflow
$40,432K
Canceled cashflow
$45,570K
Purchases of marketable
securities
$82,725K
(-18.73%↓ Y/Y)
Net loss
-$39,941K
(27.93%↑ Y/Y)
Purchases of property and
equipment
$1,184K
(-38.14%↓ Y/Y)
Revenue interest
purchase agreement and...
$6,789K
Operating lease
right-of-use assets and...
-$2,005K
(61.66%↑ Y/Y)
Prepaid expenses and
other current assets
$1,702K
(21175.00%↑ Y/Y)
Accounts receivable, net
$1,198K
(-53.31%↓ Y/Y)
Other Noncash Income
Expense
$120K
(379.07%↑ Y/Y)
Investment amortization
$112K
(-93.44%↓ Y/Y)
Increase Decrease In
Other Operating...
$103K
(2160.00%↑ Y/Y)
Back
Back
Cash Flow
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)
source: myfinsight.com